Navigation Links
Aethlon Medical (AEMD) Note: Since September 30th, 2011 / Thank You Shareholders
Date:2/5/2013

this datapoint in a future CEO note.

As the result of our HCV treatment outcomes, the Medanta Medicity Institute is now offering Hemopurifier® therapy on a compassionate-use basis to HCV-infected individuals.

We submitted an Investigational Device Exemption (IDE) to the FDA to request permission to initiate a clinical feasibility study HCV infected individuals who would be enrolled to receive Hemopurifier® therapy.  We have since received comments and study design considerations back from FDA and are preparing a response that we hope will lead to the initiation of U.S. clinical studies.

Since September 30th, 2011, we advanced studies that validated the ability of our Hemopurifier® to capture exosomes underlying different forms of cancer.  Tumor-secreted exosomes have been discovered to play a vital role in cancer progression and it has recently become clear that a successful war against cancer will need to address these particles.  Our Hemopurifier® is the first therapeutic candidate to address tumor-secreted exosomes.

We expanded our intellectual property portfolio of pending and issued patents.  As the result of our early exosome research, we were recently issued a patent that protects our cancer treatment strategy in the United States for the next two decades. 

We disclosed that researchers at the Morehouse School of Medicine discovered that the Hemopurifier® captures HIV exosomes, which transport NEF protein to assist HIV in maintaining the suppression of the immune system, even when antiviral drugs are able to achieve undetectable viral load in treated patients.  

We began shipping our exosome assay (ELLSA), which we originally created to support our own research, to researchers who are utilizing its capabilities to create new diagnostic tools that have the potential to identify a variety of disease conditions in blood and u
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Aethlon Medical Discloses CEO Interview
2. Aethlon Medical (AEMD) Note: Extracorporeal Methods to Reduce Inflammation in Sepsis
3. Aethlon Medical To Present Today At The 15th International Conference On Dialysis
4. Aethlon Medical Announces the Appointment of Laszlo Radvanyi, Ph.D. to its Scientific Advisory Board
5. Aethlon Medical (AEMD) Note: A Medical Device Strategy to Address Metastatic Melanoma
6. Aethlon Medical Receives Intent to Issue Notice on European Patent to Remove Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and Other Viral Pathogens From Blood
7. Aethlon Medical Discloses MD Anderson Cancer Center Presentation
8. Aethlon Medical Discusses Therapeutic Device Strategies to Address Cancer, Hepatitis-C and Sepsis with the Wall Street Transcript
9. Aethlon Medical Announces Renewal of DARPA Dialysis-Like Therapeutics Contract
10. Aethlon Medical Announces the Appointment of Thomas V. Wornham and Philip A. Ward to its Board of Directors
11. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  OncoGenex Pharmaceuticals, Inc. ... report its second quarter 2015 financial results on Thursday, ... call and live webcast at 4:30 p.m. Eastern Time ... programs and a general corporate update. ... Relations page of the OncoGenex website at www.oncogenex.com ...
(Date:7/30/2015)... July 30, 2015 Tianyin Pharmaceutical Inc. (NYSE ... that specializes in the patented biopharmaceutical, modernized traditional Chinese ... provided updates regarding the notice it received on May ... indicating that the Company was below certain of the ... 134 and 1101 of the NYSE MKT Company Guide, ...
(Date:7/30/2015)... , July 30, 2015 Future ... report titled, "Continuous Glucose Monitoring Systems Market: Global Industry ... the report, the global continuous glucose monitoring systems market ... is expected to reach US$ 788.4 Mn by 2020, ... 2015 to 2020. Global continuous glucose monitoring ...
Breaking Medicine Technology:TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4
... June 2 /PRNewswire-Asia-FirstCall/ -- Renhuang,Pharmaceuticals, Inc. (Pink Sheets: ... botanical products,bio-pharmaceuticals and traditional Chinese medicines ("TCM") in China ... 9:00 a.m. Eastern Time on Tuesday,June 8, 2010 ... its,fiscal year 2010, ended April 30, 2010 . , ...
... UNION CITY, Calif. , June 2 Questcor Pharmaceuticals, ... the Jefferies 2010 Global Life Sciences Conference on Thursday, June 10, 2010 ... Don M. Bailey , President and Chief Executive Officer, will discuss the ... . , , , ...
Cached Medicine Technology:Renhuang Schedules Conference Call to Discuss FY 2010 Second Quarter Results 2Renhuang Schedules Conference Call to Discuss FY 2010 Second Quarter Results 3Questcor to Present at the Jefferies 2010 Global Life Sciences Conference 2
(Date:8/1/2015)... , ... August 01, 2015 , ... On Tuesday, July ... , who are thought to have been behind the attack on Anthem Inc. which ... were zero day exploits, watering hole attacks and spear phishing campaigns. , ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... High Times magazine. What are the STASH awards? The Significant Technological Achievements ... by the cannabis-cultivation community as well as tried-and-true products that have stood the ...
(Date:7/31/2015)... IL (PRWEB) , ... July 31, 2015 , ... Ticket ... which is currently going on in Chicago at Grant Park. The festival will ... corner of North America to Chicago for the annual Lollapalooza. This unique and ...
(Date:7/31/2015)... ... July 31, 2015 , ... Sculpted Contours Luxury Medical Aesthetics announces the arrival ... Zeltiq Aesthetics released this new applicator in the United States as an upgrade to ... thighs. The original applicator required a 2 hour treatment time. The new ...
(Date:7/31/2015)... ... July 31, 2015 , ... M3 USA MDLinx.com, source of the ... new Board Exam Courses. , The additions of Gastroenterology, Pulmonology and Allergy/Immunology round ... MDLinx makes preparing for the exam easy and painless. MDLinx offers thousands of ...
Breaking Medicine News(10 mins):Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3
... HI---As school buses drive down the gravel roads in Dunn ... clouds of dust left in their wake contain such high ... the air every day are at an increased risk of ... the lungs, new research shows. Erionite is a natural mineral ...
... Laws, a second-year student in the master of social work ... Social Work (GCSW), is one of five outstanding graduate students ... for Mental Health. "Ana Luisa Laws clearly is ... ever had in the University of Houston Graduate College of ...
... News) -- Children and teens with abnormal development of the ... sports, such as soccer and basketball, are at greater risk ... Swiss researchers explained that deformities of the top of ... reduced rotation and pain during movement among young competitive athletes. ...
... Is it possible to predict whether someone is likely ... A new study by researchers at Wake Forest Baptist ... people, the first heart attack is more likely to be ... of the Epidemiological Cardiology Research Center (EPICARE) at Wake Forest ...
... a picture of many trees, young people will tend to say: ... likely we are to notice a single tree before seeing the ... the bigger picture is slower in older people. In a new ... researchers have found that these age-related changes are correlated with a ...
... SUNDAY, July 24 (HealthDay News) -- For patients suffering chest ... therapy may result in severe bleeding without reducing the risk ... A trial evaluating the combination treatment was halted early when ... became apparent. "It is very clear there is an ...
Cached Medicine News:Health News:New study finds cancer-causing mineral in US road gravel 2Health News:New study finds cancer-causing mineral in US road gravel 3Health News:University of Houston student awarded Hogg Foundation Scholarship 2Health News:Predictors of dying suddenly versus surviving heart attack identified 2Health News:Older people find it harder to see the wood for the trees 2Health News:Anti-Clotting Drug May Cause Severe Bleeding With No Benefit 2Health News:Anti-Clotting Drug May Cause Severe Bleeding With No Benefit 3
The K-ASSAY ITA Lyophilized Multi-Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assays for the li...
... K-ASSAY ASO / RF / ... to be used as a ... concentration for monitoring the performance ... Rheumatoid Factor (RF), and C-Reactive ...
... The Directigen EZ Flu A+B test ... direct and qualitative detection of influenza A ... and throat swabs of symptomatic patients. The ... differentiated test, such that influenza A viral ...
... The InVance Male Sling System is an ... mild to moderate stress urinary incontinence in ... solution for men who are not candidates ... limited manual dexterity, limited mental capacity or ...
Medicine Products: